| Execution period | 12 months |
|---|
NSE filing, NSE: CHEMCON. Summary written from the filing by ALFA Finder's alert engine.
Chemcon Speciality Chemicals Ltd: key numbers
- Share price
- ₹186.67
- Market cap
- ₹683.8 Cr
- Revenue (annual)
- ₹240.0 Cr
- Net profit (annual)
- ₹23.60 Cr
- P/E (TTM)
- 22.8×Sector 34.1×
- Promoter holding
- 74.47%+0.00% QoQ
- FII holding
- 0.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemcon Speciality Chemicals Ltd
All →Chemcon Speciality Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹65.4 Cr (+22% YoY), EBITDA ₹11.0 Cr (16.9% margin), PAT ₹7.5 Cr (+31%). H1 FY27 revenue ₹131.9 Cr (+23%). Organic chemicals strong; bromides weak.
Chemcon Speciality Chemicals Board Meeting Outcome
Chemcon Speciality Chemicals (543233) held its 24 October 2026 board meeting to consider a dividend but did not approve or recommend one. The board unanimously deferred the proposal, so no dividend was declared.
Chemcon Speciality Chemicals Q2 FY27 Results: Net Profit ₹7.5 Cr, Up 31.6% YoY
Chemcon Speciality Chemicals Ltd reported revenue from operations of ₹65.4 Cr (+21.8% YoY) and net profit of ₹7.5 Cr (+31.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹7.5 Cr · +31.6% YoY
Chemcon Speciality Chemicals Board Meeting Date
Chemcon Speciality Chemicals will hold a board meeting on October 24, 2026, to consider financial results for the quarter and half year ended September 30, 2026.
Chemcon Speciality Chemicals Other Announcement
Chemcon Speciality Chemicals Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Chemcon Speciality Chemicals Other Announcement
Chemcon cancelled its analyst/institutional investor meeting scheduled for 23 September 2026 due to business exigencies. No new information was disclosed.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.